gene therapy

Taysha Announced New Clinical Data from the REVEAL Phase 1/2 Adolescent & Pediatric Trial Evaluating TSHA-102

FDA Selects Neurogene Rett Program for START Pilot Program

Taysha Rett Program Updates March 2024

Neurogene Announces Updates to Pediatric Gene Therapy Clinical Trial

Taysha Provides Updates for all their Clinical Trials (CAN, US, UK)

A Concise Summary of Gene Therapy Clinical Trials for Rett Syndrome

First Pediatric Patient Dosed in Taysha US Clinical Trial

Taysha Pediatric Gene Therapy Trial Is Open for Enrollment in US

Neurogene Doses First Two Patients in Pediatric US Trial

Taysha Expands Age Eligibility for Canadian Clinical Trial

Taysha Cleared to Dose Second Patient in Gene Therapy Trial

Lutz and Liu Dream Team Awarded $23 Million to Cure Four Rare Diseases: Rett is One of Them

Taysha Gene Therapies Doses First Rett Syndrome Patient

Neurogene Shares Key Information on Gene Therapy Clinical Trial with the Rett Community

Cures for Many Rare Disorders Will Come More Quickly Because of Digital Natural History Studies

Neurogene Receives FDA Approval for Gene Replacement Clinical Trial for Rett Syndrome

What We Accomplished in 2022

Leading the Cure for Rett: In Gene Replacement, There’s No Replacement for RSRT